Daping Hospital And The Research Institute Of Surgery Of The Third Military Medical University

This study will test a new robotic surgery that uses only one small cut to remove stomach cancer. It includes 20 adults aged 18-75 with early or locally advanced stomach cancer. The main goal is to see if the procedure is safe and works well by tracking any problems during or wit…

This study tests whether injecting a blue dye (mitoxantrone) into the thyroid during robotic surgery helps surgeons remove more cancerous lymph nodes while protecting the parathyroid glands. About 114 adults with papillary thyroid cancer will be randomly assigned to get the dye o…

This study tests a new surgical technique called Expansion-floating Craniotomy for people with life-threatening brain swelling after a massive stroke. The new method aims to relieve pressure on the brain while keeping the skull bone in place, potentially avoiding a second surgery…

This study tests a new surgical technique called ICG-OSA for people with esophageal cancer. The goal is to see if it lowers the chance of a dangerous leak where the esophagus is reconnected to the stomach. About 73 adults will get this procedure, which uses a special dye to check…

This early-phase study tests whether low-dose radiation to the whole abdomen, followed by a special chemotherapy given into the belly and an immunotherapy drug, is safe and works for people with stomach or colorectal cancer that has spread to the lining of the abdomen. About 9 to…

This study tests whether a special radiation pattern (high and low doses) followed by a targeted drug and immunotherapy can shrink tumors in people with advanced colorectal cancer that hasn't responded to prior treatments. About 33 adults with a specific type of colorectal cancer…

This study tests a new imaging method called 68Ga-1A12 PET to detect fibrosis (scarring) in organs like the lungs. It aims to provide a non-invasive alternative to biopsies for diagnosing and monitoring fibrosis. The study will enroll 50 adults suspected or confirmed to have fibr…

This study will test a new imaging drug called Trap-(FAPI)3 to see if it can improve PET scans for people with lung nodules. The drug is designed to stick to tumors more strongly and stay longer, which may help doctors find and diagnose lung nodules more accurately. About 50 adul…

This study will test a new imaging agent called 68Ga-DOTA-BLP in 50 adults with confirmed cancer. The goal is to see if a PET scan using this agent can noninvasively detect PD-L1, a protein that helps tumors hide from the immune system. This could help doctors better diagnose can…

This study tests a special PET scan probe that targets a protein called DDR2, which is found in high levels in scarred lung tissue. The goal is to see if this probe can help doctors diagnose interstitial lung disease (a group of lung scarring conditions) earlier and more accurate…

This study will use a special PET scan to track where the drug ivonescimab goes in the body of people with esophageal cancer. The goal is to see if the drug reaches the tumor and how it spreads, which could help doctors choose better treatments. About 50 adults with esophageal ca…

This study tests whether an oral postbiotic supplement called JK-5G can help people with advanced non-small-cell lung cancer who are experiencing cachexia—a condition causing severe weight loss and muscle wasting. About 150 participants will receive either JK-5G or a placebo for …